The Role of SR-BI in sepsis: leveraging mechanistic insights to advance precision steroid therapy
According to the Surviving Sepsis Campaign, 50.3% of septic shock patients received steroid/glucocorticoid (GC) therapy. However, whether GC therapy is beneficial and who might benefit from it are hotly debated. Initial guidelines recommended GC therapy for septic patients with adrenal insufficiency...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1643395/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|